Literature DB >> 17028372

Ataxia-telangiectasia and related diseases.

Pierre-Olivier Frappart1, Peter J McKinnon.   

Abstract

Appropriate cellular signaling responses to DNA damage and the ability to repair DNA are fundamental processes that are required for organismal survival. Ataxia-telangiectasia (A-T) is a rare neurodegenerative disease that results from defective DNA damage signaling. Understanding the molecular basis of A-T has provided many critical insights into the cellular response to DNA double-strand breaks (DSBs). A-T is a syndrome that shows pronounced neurodegeneration of the nervous system coincident with immune deficiency, radiosensitivity, and cancer proneness. A-T results from inactivation of the A-T mutated (ATM) kinase, a critical protein kinase that regulates the response to DNA-DSBs by selective phosphorylation of a variety of substrates. Therefore, understanding the ATM signaling program has important biological ramifications for nervous system homeostasis. Underscoring the importance of the DNA-DSBs response in the nervous system are other diseases related to A-T that also result from defects in this signaling pathway. In particular, defects in the DNA damage sensor, the Mre11-RAD50-NBS1 complex, also lead to syndromes with neurological deficits and overlapping phenotypes to A-T. Collectively, these diseases highlight the critical importance of appropriate responses to DNA-DSBs to maintain homeostasis in the nervous system.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028372     DOI: 10.1385/NMM:8:4:495

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  130 in total

Review 1.  Partners and pathwaysrepairing a double-strand break.

Authors:  J E Haber
Journal:  Trends Genet       Date:  2000-06       Impact factor: 11.639

2.  Abnormal white matter signal in ataxia telangiectasia.

Authors:  J J Ciemins; A L Horowitz
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

3.  Oropharyngeal dysphagia and aspiration in patients with ataxia-telangiectasia.

Authors:  M A Lefton-Greif; T O Crawford; J A Winkelstein; G M Loughlin; C B Koerner; M Zahurak; H M Lederman
Journal:  J Pediatr       Date:  2000-02       Impact factor: 4.406

Review 4.  The cells and molecules that make a cerebellum.

Authors:  D Goldowitz; K Hamre
Journal:  Trends Neurosci       Date:  1998-09       Impact factor: 13.837

Review 5.  Nijmegen breakage syndrome.

Authors:  I van der Burgt; K H Chrzanowska; D Smeets; C Weemaes
Journal:  J Med Genet       Date:  1996-02       Impact factor: 6.318

6.  Ataxia telangiectasia mutated deficiency affects astrocyte growth but not radiosensitivity.

Authors:  E C Gosink; M J Chong; P J McKinnon
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

7.  Human MRE11 is inactivated in mismatch repair-deficient cancers.

Authors:  Giuseppe Giannini; Elisabetta Ristori; Fabio Cerignoli; Christian Rinaldi; Massimo Zani; Alessandra Viel; Laura Ottini; Marco Crescenzi; Stefano Martinotti; Margherita Bignami; Luigi Frati; Isabella Screpanti; Alberto Gulino
Journal:  EMBO Rep       Date:  2002-02-15       Impact factor: 8.807

8.  Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.

Authors:  Y Xu; T Ashley; E E Brainerd; R T Bronson; M S Meyn; D Baltimore
Journal:  Genes Dev       Date:  1996-10-01       Impact factor: 11.361

9.  Ataxia-telangiectasia: MR and CT findings.

Authors:  L Farina; C Uggetti; A Ottolini; A Martelli; R Bergamaschi; L Sibilla; F Zappoli; M G Egitto; G Lanzi
Journal:  J Comput Assist Tomogr       Date:  1994 Sep-Oct       Impact factor: 1.826

10.  Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer.

Authors:  Kevin Spring; Farida Ahangari; Shaun P Scott; Paul Waring; David M Purdie; Philip C Chen; Kevin Hourigan; Jonathan Ramsay; Peter J McKinnon; Michael Swift; Martin F Lavin
Journal:  Nat Genet       Date:  2002-08-26       Impact factor: 38.330

View more
  20 in total

1.  Syndromes predisposing to pediatric central nervous system tumors: lessons learned and new promises.

Authors:  Anita Villani; David Malkin; Uri Tabori
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

2.  Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS.

Authors:  Erin R P Shull; Youngsoo Lee; Hironobu Nakane; Travis H Stracker; Jingfeng Zhao; Helen R Russell; John H J Petrini; Peter J McKinnon
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

Review 3.  Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target?

Authors:  Haibo Wang; Prakash Dharmalingam; Velmarini Vasquez; Joy Mitra; Istvan Boldogh; K S Rao; Thomas A Kent; Sankar Mitra; Muralidhar L Hegde
Journal:  Mech Ageing Dev       Date:  2016-09-20       Impact factor: 5.432

Review 4.  DNA strand breaks, neurodegeneration and aging in the brain.

Authors:  Sachin Katyal; Peter J McKinnon
Journal:  Mech Ageing Dev       Date:  2008-03-25       Impact factor: 5.432

Review 5.  DNA repair deficiency and neurological disease.

Authors:  Peter J McKinnon
Journal:  Nat Rev Neurosci       Date:  2009-01-15       Impact factor: 34.870

6.  Limited role of murine ATM in oncogene-induced senescence and p53-dependent tumor suppression.

Authors:  Alejo Efeyan; Matilde Murga; Barbara Martinez-Pastor; Ana Ortega-Molina; Rebeca Soria; Manuel Collado; Oscar Fernandez-Capetillo; Manuel Serrano
Journal:  PLoS One       Date:  2009-05-07       Impact factor: 3.240

7.  DMAP1 is an essential regulator of ATM activity and function.

Authors:  K Penicud; A Behrens
Journal:  Oncogene       Date:  2013-01-14       Impact factor: 9.867

8.  ISG15 deregulates autophagy in genotoxin-treated ataxia telangiectasia cells.

Authors:  Shyamal D Desai; Ryan E Reed; Shilka Babu; Eric A Lorio
Journal:  J Biol Chem       Date:  2012-12-04       Impact factor: 5.157

Review 9.  Polynucleotide kinase-phosphatase (PNKP) mutations and neurologic disease.

Authors:  Lavinia C Dumitrache; Peter J McKinnon
Journal:  Mech Ageing Dev       Date:  2016-04-26       Impact factor: 5.432

10.  The genesis of cerebellar interneurons and the prevention of neural DNA damage require XRCC1.

Authors:  Youngsoo Lee; Sachin Katyal; Yang Li; Sherif F El-Khamisy; Helen R Russell; Keith W Caldecott; Peter J McKinnon
Journal:  Nat Neurosci       Date:  2009-07-26       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.